Peripheral Nerve Society - 2023 Annual Meeting

17 - 20 June 2023

Career Development Lunch

Are you interested in getting advice from peripheral nerve clinicians and researchers? Sign up for the career development lunch on Saturday, 14 May from 12.30-13.40 EDT (US/Canada) to discuss funding opportunities, career paths, and more in a small group setting with experts in the peripheral nerve field. Registration is FREE but limited to Junior Investigators.

The Purpose of the Career Development Lunch is to:

  • Provide an inviting atmosphere for Junior Members at the PNS.
  • Share career development suggestions and personal stories.
  • Share ideas with your peers.
  • Meet others who do the same thing you do (i.e., network).
  • Address “nuts and bolts” issues and solutions to problems.
  • Discover resources and how to access them.

REGISTRATION IS OPEN!

Career Development Lunch Mentors

Jeffrey Allen, MD

Jeffrey Allen, MD

University of Minnesota, Minneapolis, MN, USA

Jeffrey Allen is an Associate Professor in the Department of Neurology at the University of Minnesota, Minneapolis, MN. He completed his neurology residency training at Tufts University, and neuromuscular fellowship at Harvard. Dr. Allen’s research has focused on defining the clinical and diagnostic boundaries of the inflammatory neuropathies, improving inflammatory neuropathy outcome measures, and investigating treatments for those disorders. He serves on the GBS/CIDP Foundation International Global Medical Advisory Board as well as the Inflammatory Neuropathy Consortium (INC) board.

Specialty: Inflammatory neuropathy
SIG Represented: Inflammatory Neuropathy Consortium (INC)

Michael Coleman, PhD, van Geest Professor of Neuroscience

Michael Coleman, PhD, van Geest Professor of Neuroscience

University of Cambridge, Cambridge, UK

Michael Coleman is the van Geest Professor of Neuroscience at Cambridge UK, studying mechanisms of axon degeneration and synapse loss. He previously led research groups in this field at the Babraham Institute, Cambridge, Cologne, Germany and Oxford, UK. His group identified the first protein known to delay degeneration of injured axons (Wallerian degeneration) leading to the discovery of a pathway of proteins influencing axon degeneration, also in disease models without physical injury. Their finding that ablation of SARM1 can rescue axons permanently following ablation of its upstream regulator NMNAT2 has generated significant Pharma interest the pathway. He also recently published rare human disorders caused by NMNAT2 mutation, a key importance to identifying individuals suited for SARM1-blocking therapies. New research has identified gain-of-function mutations of SARM1 leading to constitutive hyperactivation in ALS patients. We are now looking for collaborations enabling similar methods to test the involvement of SARM1 and NMNAT2 in peripheral neuropathies.

Specialty: Neuroscience
SIG Represented: Toxic Neuropathy Consortium (TNC)

Keith Fargo, PhD

Keith Fargo, PhD

CMT Research Foundation, Naperville, IL, USA

Keith joined the CMT Research Foundation as Chief Scientific Officer after working for 23 years in the research field, including clinical trials, academia, and nonprofit experience. Most recently, Keith worked for seven years at the Alzheimer’s Association, where he led efforts to grow the largest international research conference and scientific society related to dementia science, along with growing engagement in clinical trials. He also led the team of researchers who annually produced Alzheimer’s Disease Facts and Figures, the definitive source of information related to Alzheimer’s incidence and prevalence, mortality and morbidity, and use and costs of care. Keith also brings expertise in public communication of research, making science accessible to people of all backgrounds. After earning his PhD in neuroscience at Indiana University, Keith worked in peripheral nerve science at Edward Hines, Jr, VA Hospital in the Rehabilitation Research & Development Service, and at Loyola University Chicago—Stritch School of Medicine in the Department of Molecular Pharmacology and Therapeutics. Keith joined the CMT Research Foundation in order to help catalyze scientific progress in this exciting field. He is based in the Chicago area with his wife Susan and 3 children, where they enjoy family life, reading, and Formula 1 racing.

Specialty: CMT / Inherited peripheral neuropathies
SIG Represented: Charcot-Marie-Tooth and Related Neuropathies Consortium (CMTR)

Vera Fridman, MD

Vera Fridman, MD

University of Colorado, Englewood, CO, USA

I am currently an Associate Professor in the Neuromuscular Section at the University of Colorado, where I direct the Charcot-Marie-Tooth Association Center of Excellence. I completed my Neurology Residency at the University of Pennsylvania and a Neuromuscular Disease Fellowship at Brigham and Women’s and Massachusetts General Hospitals, followed by a Clinical Research Fellowship in Hereditary Neuropathy through the Inherited Neuropathies Consortium (INC). My research has focused on natural history studies in CMT in collaboration with the INC, as well as on translational studies evaluating the potential role of atypical, neurotoxic sphingolipids in diabetic neuropathy (DN). I am currently examining sphingolipid biomarkers, as well as other emerging plasma markers, in youth and adults with T2D and DN with the support of an NIH Mentored K23 Patient-Oriented Research Career Development Award.

Specialty: Genetic and metabolic peripheral neuropathy
SIG Represented:
IDNC

Christopher Gibbons, MD, MMSc

Christopher Gibbons, MD, MMSc

Harvard Medical School, Boston, MA, USA

Christopher Gibbons is an Associate Professor of Neurology at Harvard Medical School and on staff at Beth Israel Deaconess Medical Center and Joslin Diabetes Center in Boston, Massachusetts. Dr. Gibbons is the director of the Joslin Diabetes Center neuropathy clinic and is director of the Neurocutaneous skin biopsy lab at Beth Israel Deaconess Medical Center. He is former Chair for the Autonomic Section of the American Academy of Neurology and Past-President of the American Autonomic Society. Dr. Gibbons currently serves as Past-Chair of the International Diabetes Neuropathy Consortium. Dr. Gibbons is actively engaged in clinical/translational research and has published extensively on peripheral and autonomic neuropathies. His current areas of research include: 1) defining the mechanisms and pathophysiology underlying the development of treatment induced neuropathy of diabetes – an iatrogenic painful autonomic neuropathy associated with treatment of diabetes and 2) developing a novel biomarker for neurodegenerative disorders by measuring alpha-synuclein within cutaneous autonomic nerve fibers. Dr. Gibbons has received research funding through the NIH (NINDS), the Goldberg Foundation, the Michael J. Fox Foundation, the Juvenile Diabetes Research Foundation, Grifols and Celgene. Dr. Gibbons is a co-founder of CND Life Sciences.

Specialty: Diabetic Neuropathy, autonomic disorders
SIG Represented: International Diabetes Neuropathy Consortium (IDNC)

Divyanshu Dubey, MD

Divyanshu Dubey, MD

Mayo Clinic, Rochester, MN, USA

Dr. Divyanshu Dubey is an Associate Professor of Neurology at Mayo Clinic, Rochester, MN. His research focus is peripheral and central autoimmune neurological conditions. This includes search for novel biomarkers and analysis of clinical and radiological features of autoimmune neurological disorders. He has authored more than 120 peer reviewed articles including first or senior author papers in various high impact factor journals.

Specialty: Autoimmune Neurology
SIG Represented: Inflammatory Neuopathy Consortium (INC)

Claudia Sommer, MD, Prof. Dr. med.

Claudia Sommer, MD, Prof. Dr. med.

Universitätsklinikum Würzburg, Würzburg, Germany

Claudia Sommer is a Professor of Neurology at the University of Würzburg, Germany. Research interests are immune neuropathies and the pathophysiology of pain and of antibody-mediated diseases. She has written more than 250 original research papers and more than 100 reviews and book-chapters and edited several books. Dr. Sommer is active in the development of national and international guidelines on immune neuropathies, diagnosis and treatment of peripheral neuropathies, on nerve and skin biopsies, and on neuropathic and primary pain syndromes. Currently, she serves as deputy editor of the European Journal of Neurology. She is a PNS Board member, immediate past president of the German Pain Society and president of the International Association for the Study of Pain (IASP).

Specialty: Immune neuropathies, neuropathic pain
SIG Represented: Neuropathic Pain Consortium (NPC)

Nathan Staff, MD, PhD

Nathan Staff, MD, PhD

Mayo Clinic, Rochester, MN, USA

Dr. Nathan Staff is a neurologist, Professor, and Vice Chair of Research in the Department of Neurology at Mayo Clinic Rochester who cares for patients with neuromuscular diseases such as amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease) and peripheral neuropathy. After completing his Bachelor of Science at the University of Minnesota, he received his Medical Degree and Ph.D. in neuroscience from Northwestern University. He then was a resident and chief resident at Mayo Clinic Rochester, with subsequent sub-specialization training in clinical neurophysiology and peripheral nerve disorders. Dr. Staff is highly involved in patient care, education, and research at Mayo Clinic. Regarding patient care, he is the Director of the ALS Multidisciplinary Clinic, which provides long-term care for over 100 local patients yearly with ALS. This is in addition to the hundreds of national and international referrals for ALS that yearly come to Mayo. Dr. Staff’s research efforts employ regenerative medicine strategies in both laboratory-based model systems and human clinical trials in order to study disorders that damage the peripheral nervous system. His emphasis has been primarily on ALS and chemotherapy-induced peripheral neuropathy (CIPN), two diseases with high clinical morbidity. He and his colleagues have led Mayo Clinic’s Clinical Trials studying injection of autologous mesenchymal stem cells into the spinal fluid of patients with ALS. In the laboratory, he utilizes patient-derived induced pluripotent stem cell (iPSC) technology to study mechanisms of neuromuscular diseases in vitro, with a focus on CIPN.

Specialty: Neurology, Mechanisms of CIPN, Postsurgical Inflammatory Neuropathies, ALS
SIG Represented: Toxic Neuropathy Consortium (TNC)

Haesun Kim, PhD

Haesun Kim, PhD

Rutgers University, Newark, NJ, USA

Dr. Kim is a Professor of Cell Biology and Director of the Graduate Program in Biology at Rutgers University. Dr. Kim grew up in Korea and studied horticulture as an undergraduate student. After moving to the USA as a graduate student at the University of Cincinnati, she was introduced to the fascinating world of Schwann cells by Dr. Nancy Ratner and began her research training investigating Schwann cell hyperplasia associated with Neurofibromatosis. After completion of her Ph.D. degree, she joined Dr. Charles Stiles’ lab (Dana-Farber Cancer Institute) as a post-doctoral fellow and studied cell cycle progression in Schwann cell following PNS injury. Dr. Kim has been a faculty at Rutgers University since 2004, leading a research group that investigates the molecular mechanisms that regulate Schwann cell plasticity and myelin homeostasis. As the Graduate Program Director, Dr. Kim enjoys her interaction with graduate students and her role as a faculty mentor. Dr. Kim also serves as a mentor within the Rutgers Connection Network Mentoring program, which is designed to increase the engagement and scholarly productivity of junior faculty and postdoctoral researchers.

Specialty: Schwann cells, Myelin, CMT, PNS injury
SIG Represented: Charcot-Marie-Tooth and Related Neuropathies (CMTR)

Mario Saporta, MD, PhD, MBA

Mario Saporta, MD, PhD, MBA

University of Miami, Miami, FL, USA

Mario Saporta, MD, PhD, MBA is an Associate Professor of Neurology and Human Genetics at the University of Miami, where he directs the UM Muscular Dystrophy Association Care Center and CMT Center of Excellence. He coordinates a multidisciplinary clinical team that provides specialized care for patients with neuromuscular genetic disorders, with a focus on the inherited peripheral neuropathies. As a physician-scientist, Dr. Saporta is also a principal investigator of the CMT Translational Program at UM. He leads a research group that uses patient-derived motor neurons to model genetic neuropathies and create platforms for therapy development. He is currently the Principal Investigator for the Pharnext Premier trial in CMT1A for North America.

 After completing his Neurology training in his home country of Brazil, Dr. Saporta trained in neuromuscular and electrodiagnostic medicine, with emphasis in the peripheral neuropathies, in centers in the United Kingdom (Institute of Neurology, University College London), France (Centre Hospitalier Universitaire de Bicêtre) and the US. He did his Neuromuscular/Neurophysiology fellowship at the Detroit Medical Center, home to the largest inherited neuropathy clinic in the world at the time, and was the first clinical research fellow of the NIH Inherited Neuropathy Consortium. Dr. Saporta has published extensively on the pathophysiology of different types of inherited peripheral neuropathies, using various disease models, including patients’ skin biopsies, knockin mouse models and induced pluripotent stem cell derived motor neurons from patients with CMT. Dr. Saporta’s current research interest is the identification of disease mechanisms in neurofilament-associated CMT and the use of cellular reprogramming and differentiation to enable therapy development for genetic neuropathies in general.

Specialty: Genetic neuropathies/Therapy development

SIG Represented: Charcot-Marie-Tooth and Related Neuropathies (CMTR)

PNS Executive Office:
1935 County Road B2 W · Suite 165 | Roseville, MN 55113 USA | +1.952.545.6284 | info@PNSociety.com
2021 Peripheral Nerve Society. All Rights Reserved.
Site by The Lone Designer | Privacy Policy | Terms of Service | Cookie Policy
Facebook Twitter